Lv2
104 积分 2023-12-13 加入
Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
1天前
已完结
Emerging Pharmacotherapies for Obesity: A Systematic Review
2天前
已完结
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
2天前
已完结
Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
2天前
已完结
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials
2天前
已完结
Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials
2天前
已完结
Glucagon, from past to present: a century of intensive research and controversies
4天前
已完结
Regular aerobic exercise and blood pressure in East Asians: A meta-analysis of randomized controlled trials
14天前
已完结
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
18天前
已完结
Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity
1个月前
已完结
皖公网安备34019202002308
